Clinical Trial Update: Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy [NA]

View source ↗

Summary

A completed randomized trial comparing Procrit (epoetin alfa) versus no Procrit in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, or Burkit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Burkitt Lymphoma
• Lymphoblastic Lymphoma

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | NA | Status: COMPLETED | Results posted: 2012-08-27